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Objective:This study audited operative risk in patients undergoing urgent carotid surgery for crescendo transient ischemic
attacks (TIAs).
Methods: Interrogation of the vascular unit database (January 1992 to July 2004) identified 42 patients operated on
urgently for crescendo TIAs, which were defined as >3 TIAs within the preceding 7 days. Stroke, death, and any major
cardiac events were analyzed.
Results: Thirty-nine patients underwent conventional endarterectomy, and three underwent interposition vein bypass.
Crescendo TIA patients had sustained a median of five TIAs (range, 3 to 20) in the 7 days before surgery. Three patients
died or had a stroke after surgery, for a combined stroke/death rate of 7%. This compares with 2.4% in 1000 patients
undergoing elective carotid endarterectomy in this unit during the same time period. The combined stroke/death/major
cardiac event rate was 14% (n  6).
Conclusions: The combined risk of neurologic and cardiac complications after urgent carotid surgery for crescendo TIA is
higher than that expected after elective cases but is still acceptable considering the natural history of patients with unstable
neurologic symptoms. (J Vasc Surg 2007;45:1148-54.)The role of urgent carotid endarterectomy (CEA) for
neurologically unstable patients with deficits of recent on-
set has not been adequately defined. In the past, recon-
struction of the internal carotid artery (ICA) has been
offered for several urgent indications such as recurrent or
crescendo transient ischemic attacks (TIAs), acute or recur-
rent stroke, progressing stroke with fluctuating or evolving
pattern, and recent total ICA occlusion. Reports on the
results of urgent surgical treatment usually group all these
urgent indications together or mix outcomes of these pro-
cedures with stable symptomatic or even asymptomatic
patients.1-30 Furthermore, they usually report a small num-
ber of patients over a long period of time. As a result,
reliable evidence about the effectiveness of surgery in the
urgent or emergency setting is lacking. An accurate defini-
tion of crescendo TIAs remains unanswered in the literature
because some investigators use the term arbitrarily and
others do not provide a definition at all.
Finally, it was our impression that these neurologically
unstable patients are also at higher risk for acute cardiac
complications as a result of systemic inflammation or ath-
erosclerotic plaque instability, or both, or because of the
large burden of coronary artery disease in this population.
In this study, we aimed to test the above hypothesis and
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1148reviewed our experience with patients presenting with cre-
scendo TIAs during the last 12 years, with a particular
emphasis on cardiac events.
METHODS
The vascular database of our unit was interrogated to
identify patients undergoing urgent carotid surgery for
crescendo TIAs between January 1992 and July 2004. One
of the problems in the carotid literature is the lack of an
accurate definition of what constitutes TIAs with a cre-
scendo pattern. Traditionally, crescendo TIAs involve re-
peated TIAs within a relatively short period of time. On
each occasion, the neurologic deficit will have fully recov-
ered before the onset of the next event, and these may
occur daily or be more frequent and more severe.
Because no agreement has been reached on the actual
definition of crescendo TIAs, for the purposes of this study,
we thus defined crescendo TIAs as 3 TIAs in the preced-
ing 7 days. Those operated on urgently for recurrent TIAs
but who had experienced 3 TIAs during the previous 7
days were excluded. Patients with crescendo neurologic
symptoms undergoing external carotid endarterectomy in
the presence of an occluded ICA were also excluded.
Patient details, including age, gender, hypertension,
coronary artery disease, smoking, diabetes, peripheral vas-
cular disease, renal impairment, and hypercholesterolemia
were collected and were entered in an Excel database
(Microsoft Ltd, Reading, UK).
Patients underwent a brain computed tomography
(CT) scan to confirm the diagnosis and rule out intracranial
hemorrhage, subdural hematoma, or intracranial patholo-
gies other than acute cerebral ischemia. The extracranial
carotid arteries and plaque morphology were assessed by
duplex scanning performed by an experienced vascular
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arterial digital subtraction angiography (DSA) or magnetic
resonance arteriography (MRA) were inconclusive find-
ings, such as inability to obtain satisfactory images of the
bifurcation, inability to visualize the distal ICA, abnormal
common carotid waveform suggestive of proximal disease,
and a high-resistance signal in the distal ICA suggestive of
a siphon disease.
The criterion for surgery by carotid noninvasive testing
was a 70% stenosis of the ipsilateral ICA. No patient in
this series had been operated on with a less severe stenosis.
If there were either an atypical presentation or concerns
about other sources of cerebral embolization, such as car-
diac causes, a cardiology opinion and transthoracic or trans-
esophageal echocardiography, or both, were requested. No
atypical cases were included in the present series.
After verifying the diagnosis and demonstrating the
absence of hemorrhagic infarction, all patients were system-
ically anticoagulated with at least 1000 U/h of heparin.
Patients usually underwent operation on the first available
scheduled vascular operating list.
CEA was undertaken with the utmost care during
carotid dissection with the aim of achieving early distal ICA
control and avoiding distal embolization of loose thrombus
and debris. All procedures were performed by a consultant
vascular surgeon or supervised trainee with normotensive,
normocarbic general anesthesia using loupe magnification,
systemic heparinization (5000 U), routine shunting
(Pruitt-Inahara, Ideas for Medicine, North Clearwater,
Fla), tacking sutures to the distal intimal step to prevent
intimal dissection, and routine patch angioplasty. Blood
flow velocity in the middle cerebral artery (MCA) was
monitored throughout the procedure using 2-MHz pulsed
wave transcranial Doppler (TCD) ultrasound imaging with
a fixed head probe system (SciMed PC2-64B, Scimed UK
Ltd, Bristol, UK) protected by a semi-circular metal head
guard.
A 5-mm segment of the anastomosis adjacent to the
orifice of the external carotid artery was left open. The
shunt was removed, and the lumenwas vented and irrigated
with heparinized saline. Before final closure and restoration
of flow, the lumen was inspected with a flexible hystero-
scope (Olympus 1070-48, Hamburg, Germany) to exclude
residual luminal thrombus and intimal flaps.
Where simple CEA was not technically feasible, a com-
mon-to-internal carotid interposition bypass was per-
formed with the use of reversed great saphenous vein
retrieved from the thigh area. After recovery from anesthe-
sia, the patient was transferred to the recovery area of the
operating theater or to the high dependency unit for a
3-hour period of TCD monitoring. Previous work in this
department has demonstrated postoperative TCD moni-
toring and selective administration of Dextran-40 emboli
to be successful in reducing embolization and progression
to stroke.31 The protocol of our unit was to administer
Dextran-40 to any patient who had (1) 25 emboli in any
10-minute period or (2) emboli that distorted the MCA
waveform, suggesting that they were large.The main outcome measures were stroke, death, and
major cardiac events30 days. Any new neurologic deficit
lasting 24 hours was classified as a stroke, and these
patients were investigated by CT scan/autopsy, duplex
assessment of the ICA, and TCD assessment of the intra-
cranial vessels, as appropriate. Major cardiac events were
defined as Q and non-Q wave myocardial infarction (MI),
congestive heart failure, unstable angina, and ventricular
tachyarrhythmias. MI was defined as including two or more
of the following criteria: cardiac enzyme levels 5% or
troponin concentration 1.3 g/L, ischemic changes on
electrocardiogram (ECG), or chest pain for 30 minutes.
Non-Q wave MI was defined as elevated cardiac en-
zyme levels with no ECG changes. Minor cardiac events
included less severe episodes of angina or arrhythmias not
requiring treatment in an intensive care unit/coronary care
unit setting. Because some patients may have angina or
arrhythmias preoperatively, only new episodes of angina or
arrhythmias were recorded. Serial ECGs and cardiac en-
zyme assays were not obtained routinely and were only
requested if there were clinical symptoms, ST segment
changes on continuous ECGmonitoring, or hemodynamic
instability.
RESULTS
During the study period, 42 patients (33 men, 9
women) with a median age of 66 years (range, 48 to 87
years) underwent urgent carotid surgery. The patient de-
mographics and medication history are summarized in Ta-
bles I and II, respectively. All were taking aspirin (n  39)
or clopidogrel (n  3) preoperatively. Patients had experi-
enced a median of five TIAs during the 7 days before
admission (range, 3 to 20). Presenting symptoms were
typical lateralizing TIAs in 41 patients, amaurosis fugax and
TIA in 11, and recurrent episodes of amaurosis fugax in
one. No patient presented with atypical symptoms.
All but two were systemically heparinized for a median
of 3 days (range, 1 to 7 days). These two patients were
planned admissions from the urgent waiting list for an
elective CEA. During pre-clerking, however, they admitted
Table I. Patient demographics
Patient details N, (%)
Age, median (range) 66 (48-87)
Male/female 33/9
Ischemic heart disease 24 (57)
Myocardial infarction 16 (38)
Angina 16 (38)
Hypertension 28 (67)
Diabetes 4 (10)
Renal impairment 4 (10)
Peripheral vascular disease 8 (19)
Hypercholesterolemia 17 (40)
Smokers (current or ex) 32 (76)
Previous contralateral CEA 4 (10)
CEA, Carotid endarterectomy; CT, computed tomographyto having experienced multiple TIAs within the previous
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administered an immediate oral dose of clopidogrel (75
mg) the same evening and underwent surgery the next
morning. In addition to duplex scanning, only two patients
underwent further imaging of the carotid arteries. One
patient underwent carotid angiography, and one patient
proceeded to MRA.
The operative details are summarized in Table III. A
total of 39 patients underwent a conventional endarterec-
tomy, all with patch closure (34 Dacron and 5 vein). Three
patients underwent interposition vein bypass, one because
of extreme tortuosity and two because of a very thin poste-
rior wall after CEA. At operation, macroscopic examination
of the excised plaques revealed ulcerated plaques with
overlying debris or thrombus in 74% of patients. TCD
monitoring of the ipsilateral MCA was used in 39 patients.
In three patients, there was no temporal window. None of
the three developed any cerebrovascular complications.
Completion angioscopy was performed successfully in
Table II. Medication history at time of admission*
Medication N
Aspirin 39
Warfarin 2
Dipyridamole 12
Clopidogrel 3
Statin 21
-blockers 9
Diuretics 19
Calcium-channel blockers 11
ACEI 9
ACEI, Angiotensin converting enzyme inhibitors.
*All patients were receiving aspirin or clopidogrel preoperatively.
Table III. Operative details*
Operative data N
General anesthesia 42
Procedures
Carotid endarterectomy 39
Interposition vein bypass 3
TCD monitoring 39
Middle cerebral artery 36
Posterior cerebral artery 3
Plaque morphology
Smooth stenosis 3
Ulceration (no overlying debris) 4
Ulceration  overlying
debris/thrombus
31
Intra-plaque hemorrhage 4
Shunting 40
Shunt time (min) 45 (31-96)
Clamp time 1 (min) 2 (1-6)
Clamp time 2 (min) 4 (3-12)
Angioscopy 39
Positive angioscopy 4
TCD, Transcranial Doppler; Clamp time 1, time from clamping to shunt
release; Clamp time 2, time from shunt clamping to flow restoration.
*Values are expressed as medians (range).39 patients. Angioscopy was not performed in three pa-tients because of equipment failure, the operation was
performed out of hours, logistical problems, and two si-
multaneous CEAs. Angioscopy was positive in four patients
(10%), where residual thrombus was detected and removed
before flow restoration; presumably, it had formed due to
bleeding from vasa vasorum or inadequately flushed arteri-
otomy. No technical defects had been detected in this
series. No patient received Dextran-40 postoperatively be-
cause none fulfilled the unit criteria for TCD-directed
Dextran therapy.
The operative results are summarized in Table IV. A
total of 16 complications occurred in 13 patients (31%).
Two patients (4.8%) had a postoperative stroke. The first
occurred in the vertebrobasilar territory on the first post-
operative day due to basilar artery thrombosis and he died 2
days later. The presence of thrombosis and pre-existing
vertebrobasilar occlusive disease was confirmed at autopsy.
The second patient developed acute congestive heart failure
and severe cardiorespiratory distress requiring reintubation
and ventilation for 48 hours in the intensive care unit. He
was noted to have right arm weakness when he was extu-
bated, and a brain CT scan confirmed an infarct in the
ipsilateral MCA territory.
No statistical association was detected between the
presence of previous infarct on CT and stroke or death
(1/11 vs 2/31, P  .4). There were eight cardiac compli-
cations (5 major, 3 minor). Overall, the 30-day event rates
were 4.8% for mortality, 7% for stroke/death, and 14% for
combined stroke/death/cardiac.
DISCUSSION
Although the natural history of crescendo TIAs has not
been evaluated prospectively in large series, such symptoms
are considered a precursor to stroke.13 Medical treatment
alone is associated with a poor prognosis, an opinion largely
based on anecdotal data from the 1970s and
1980s.13,14,24,32 Crescendo TIAs represent disabling, re-
current transient cerebral or retinal ischemia characterized
Table IV. Operative results
Outcome
Crescendo TIAs
(n  42) (%)
All complications 16
Stroke 2 (4.8)
Cardiac 8
Myocardial infarction 1
Left ventricular failure 2
Angina 1
Angina (unstable) 2
Arrhythmias 2
Respiratory 2
Cranial nerve dysfunction 2
Neck hematoma 1
Retroperitoneal hematoma 1
30-day mortality 2 (4.8)
Stroke/death rate 3 (7)
Stroke/death/major cardiac event rate 6 (14)by an increased frequency, duration, or severity of events.13
strok
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ble plaque with overlying thrombus, and the patient is at
high risk of stroke. However, no consensus has been
reached on the number of TIAs or the time period needed
to define an unstable neurologic state as crescendo TIA
symptomatology.
The Charing Cross group rejects the term crescendo
TIA, because “this implies that the deficit is temporary,
whereas at the time of surgery, it is unknown whether the
patient is going to progress or to improve again from this
deficit.”4 In their series of patients with actively changing
neurologic deficits, surgical intervention occurred during
an attack, and therefore, the outcome without surgery was
unknown.
In our experience, along with that from other centers,
most patients with crescendo TIA symptoms have usually
been operated on during a symptom-free interval in an
attempt to arrest progression of the frequent TIAs to a
complete stroke.13,14,24 Several small series report a recov-
ery rate of 70% to 100% after urgent carotid surgery.24 In a
collective review of the literature (unpublished data), we
found a 6% rate for stroke and 9% for combined stroke/
death in 132 patients undergoing surgery for crescendo
TIAs during the last two decades (Table V).2,3,13-17,25-27
Comparable figures were 4.8% and 7% in our series. The
combined stroke/death rate of 1000 patients undergoing
elective CEA in this unit during the same time period was
2.4%. Nevertheless, this apparent difference was not statis-
tically significant (24 [2.4%] in 1000 vs 3 [7%] in 42; P 
.058). A recent meta-analysis from Oxford confirmed that
CEA for crescendo TIA had a much higher risk than
elective CEA for single episodes of TIA (odds ratio, 7.5;
95% confidence interval, 3.7 to 10; P  .001).33 This was
based on the results of only two series, however.9,20
After initial intravenous heparinization, some surgeons
performed emergency CEA, usually within an interval of 12
to 24 hour,13 whereas others waited slightly longer in an
Table V. Studies reporting on patients being operated up
Author & year
Patients
(M/F) Mean age (ran
Diaz,2 1985 8† (4/4) 58 (40-72) 
Ricotta,3 1985 3 (NA) NA 
Wilson,13 1993 12 (NA) 61(42-69) 
Nehler,14 1993 29 (26/3) 63 (51-83) 
Greenhalgh,15
1993
7 (5/2) 62 (55-72)
Golledge,20 1996 26 (6/20) 65 (38-82) 
Schneider,22 1999 31(NA) NA 
Paterson,25 2000 2 (2/0) 66 (63-69) 
Brandl,26 2001 7(6/1) 69 (60-84) 
Kasper,27 2001 7 (NA) NA 
Present series, 2006 42 (33/9) 66 (48-87)
Total 174 (82/39) 64 (40-87)
NA, Information not available; M, male; F, female.
*Only studies detailing information on stroke, stroke/death, and combined
†Includes four extracranial-intracranial bypasses.attempt to achieve neurologic stabilization and avoid emer-gency surgery.14 The Portland group, for example, main-
tained heparin anticoagulation for a mean of 5 days before
they proceeded to surgery. One symptomatic common
carotid occlusion and one asymptomatic ICA occlusion
occurred during preoperative heparin therapy.14 The me-
dian delay to surgery in our series was 3 days. The delay for
the individual patient had been influenced by both clinical
and logistic reasons, the main factors being whether the
patient became asymptomatic on heparin and the availabil-
ity of an emergency operating room, TCDmonitoring, and
an experienced vascular technologist. Providing the TIAs
were controlled on heparin, we preferred, as others,14 to
avoid high-risk CEAs out of hours in suboptimal condi-
tions and wait until the next available elective list.
Althoughmany of these patients become asymptomatic
on heparin, some may continue to experience sporadic
TIAs, as seen in 13 of 29 patients in the Portland group and
in four patients in the present series. Perhaps these patients
represent a subgroup at higher risk that would warrant
earlier intervention. Five of these 13 patients experienced
TIAs when heparin therapy was briefly discontinued for
carotid angiography.14 Possible reasons for the discrepancy
between the two studies may be the shorter delay to surgery
in our series and that only one patient underwent carotid
angiography.
Two of our crescendo TIA patients (who had been on
routine aspirin) were given 75 mg of clopidogrel the night
before their operation instead of receiving preoperative
heparin anticoagulation. This decision was left to the dis-
cretion of the responsible consultant but was based on
recent work from this unit that showed that combining
aspirin and clopidogrel reduces cerebral embolization in
patients undergoing CEA.34
One might thus question whether clopidogrel should
replace heparin as appropriate initial therapy in these pa-
tients. Most patients in our practice are being referred from
stroke physicians and neurologists, and they are already
rgently for crescendo transient ischemic attacks*
Stroke (%)
Stroke and
mortality (%)
Stroke, mortality and
major cardiac events
1 (12) 1 (12) 1 (12)
0 0 0
0 0 0
1 (3) 2 (6) 4 (13)
1 (14) 1 (14) 1 (14)
4 (15) 7 (27) 7 (27)
0 0 0
0 0 0
1 (14) 1 (14) 1 (14)
0 0 0
2 (5) 3 (7) 6 (14)
10 (6) 15 (9) 20 (11.5)
e/death/major cardiac events have been included.on u
ge)receiving a heparin infusion by the time they are seen by the
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support the use of clopidogrel instead of intravenous hep-
arin as the initial therapy in crescendo TIA patients. Al-
though our personal preference may change toward that
direction in the future, this policy is not evidence-based and
relies on personal experience of only two crescendo TIA
patients and extrapolating data from clopidogrel treatment
on elective CEA patients.
Of course, one might argue against this strategy given
the results of the Management of Atherothrombosis with
Clopidogrel in High-Risk Patients with Recent Transient
Ischemic Attacks or Ischemic Stroke (MATCH) trial that
demonstrated the added risk without benefit of using both
aspirin and clopidogrel in recently symptomatic patients.35
One might also argue about the optimal dose of clopi-
dogrel, because loading with 300 to 600 mg is necessary to
achieve effect within a day. Naturally, the latter dose would
have a better antiplatelet and anticoagulant effect; however,
this should be balanced against the increased risk of bleed-
ing complications seen after CEA. In any case, such data are
not available.
Others have attempted to control emboli preopera-
tively in patients with recurrent or crescendo TIAs using
TCD-directed Dextran therapy before surgery.36 These
workers studied 19 patients who had experienced two or
more TIAs within the preceding month and had TCD-
detected microemboli. Patients were given Dextran 40
infusion for a median of 5 days (range, 1 to 10 days), a
policy that was successful to control both TIAs and TCD
microembolization in all cases. One patient died from a
myocardial infarction before carotid surgery, and a nondis-
abling stroke occurred in one of the 18 patients who
underwent CEA. The main limitation was that this study
excluded patients with TIAs, but without emboli, and
patients with emboli and no symptoms.
One reason why we reviewed our experience was an
impression that (in addition to a higher of death/stroke)
these urgent patients also seemed to be at higher risk for
acute cardiac events. The prevalence of coronary artery
disease in patients with peripheral arterial disease is well
documented. In a classic study from The Cleveland Clinic,
hemodynamically significant coronary artery disease was
demonstrated (angiographically) in 32% of patients with
carotid artery disease.37 The average rate of perioperative
myocardial infarction after elective CEA is about 1.0%,38
whereas the overall cardiac event rate ranges between 2.4%
and 3.3%.39,40 This observation contrasts with the 17%
cardiac event rate encountered in the current series. This
rate may also have been underreported because the present
study was retrospective and serial ECGs and cardiac en-
zyme assays were not obtained routinely. Moreover, the
cumulative stroke/death/major cardiac event rate was
14%.
The relatively high incidence of perioperative cardiac
complications after urgent carotid surgery may seem sur-
prising, but a similar trend has been observed after other
urgent arterial procedures.37 The reasons for this are un-
clear. Among possible explanations is an incomplete preop-erative assessment with a failure to correct all preoperative
medical risk factors. Nevertheless, the higher likelihood of
cardiac complications in the neurologically unstable patient
undergoing urgent carotid surgery may also point toward a
common systemic cause for atherosclerotic plaque disrup-
tion in both the carotid and coronary vascular beds. Acute
coronary and cerebrovascular syndromes, as well as severe
peripheral artery disease, are commonly associated with
systemic evidence of inflammation, and several studies have
suggested that plaque vulnerability may be a systemic phe-
nomenon.41-43
Rothwell et al44 have shown an association between
angiographic plaque irregularities in the carotid arteries and
plaque instability and rupture in the coronary arteries,
providing indirect evidence that some individuals have a
systemic predisposition to irregularity and rupture of ath-
erosclerotic plaques. Conversely, complex coronary
plaques in a small group of patients were associated with
complex carotid plaques and the high prevalence of both
plaque types in patients with acute coronary syndrome was
indicative of a systemic process contributing to complex
plaque formation and instability.45
In a larger study, the prevalence of complex carotid
plaques was significantly higher in unstable vs stable angina
patients.46 On multivariate analysis, unstable angina and
raised C-reactive protein level were independently associ-
ated with complex carotid plaques. Similar associations
have been observed between peripheral arterial disease and
coronary events.47,48 Carotid plaque morphology has been
infrequently addressed in previous studies reporting on
patients with crescendo TIAs.13,22 At operation, approxi-
mately 80% of our patients were found to have friable and
unstable ulcerated plaques with overlying debris or throm-
bus.
Of course, one might argue against the hypothesis of
systemic plaque instability as a reason for increased cardiac
morbidity. The latter may simply reflect selection bias and
that these patients have significant pre-existing coronary
artery disease. To our knowledge, no studies have com-
pared the extent of coronary artery disease in cerebrovas-
cular patients presenting with crescendo TIAs and those
presenting with single TIAs or stable neurologic symptoms.
An alternative explanation could be the low use of periop-
erative -blockade and statins. Naturally, this series spans a
12-year period, andmany of these patients had been treated
before the cardioprotective effect of perioperative -block-
ers and the anti-inflammatory properties of statins were well
documented. In modern vascular practice, one could argue
that, considering the data of Poldermans et al,49 it is equally
important to spend the 0 to 3 days preoperatively getting
the patients appropriately -blocked as it does getting them
adequately anticoagulated.
Finally, it may well be that the conclusions of the
present study could simply represent a statistical error be-
cause of the small numbers. The latter was the reason why
a formal statistical analysis for any potential significant
variables with impact on outcome, such as patch type, the
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formed.
CONCLUSION
The combined risk of neurologic and cardiac complica-
tions after urgent CEA for unstable, crescendo-type neuro-
logic symptoms is higher than that expected after elective
cases— but still acceptable—considering the natural his-
tory of patients with unstable neurologic symptoms. The
increased likelihood of cardiac events would suggest that a
systemic trigger may mediate acute atherosclerotic plaque
disruption or may reflect the large burden of coronary
artery disease in this population.
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